chr2-27496913-C-T
Position:
Variant summary
Our verdict is Uncertain significance. Variant got 2 ACMG points: 2P and 0B. PM2
The NM_001486.4(GCKR):c.9C>T(p.Gly3=) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000196 in 1,613,612 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Genomes: 𝑓 0.00017 ( 0 hom., cov: 32)
Exomes 𝑓: 0.00020 ( 0 hom. )
Consequence
GCKR
NM_001486.4 synonymous
NM_001486.4 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: -0.0200
Genes affected
GCKR (HGNC:4196): (glucokinase regulator) This gene encodes a protein belonging to the GCKR subfamily of the SIS (Sugar ISomerase) family of proteins. The gene product is a regulatory protein that inhibits glucokinase in liver and pancreatic islet cells by binding non-covalently to form an inactive complex with the enzyme. This gene is considered a susceptibility gene candidate for a form of maturity-onset diabetes of the young (MODY). [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Uncertain_significance. Variant got 2 ACMG points.
PM2
Very rare variant in population databases, with high coverage;
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
GCKR | NM_001486.4 | c.9C>T | p.Gly3= | synonymous_variant | 1/19 | ENST00000264717.7 | NP_001477.2 | |
GCKR | XM_011532763.1 | c.9C>T | p.Gly3= | synonymous_variant | 1/13 | XP_011531065.1 | ||
GCKR | XR_001738699.1 | n.75C>T | non_coding_transcript_exon_variant | 1/13 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
GCKR | ENST00000264717.7 | c.9C>T | p.Gly3= | synonymous_variant | 1/19 | 1 | NM_001486.4 | ENSP00000264717 | P1 | |
GCKR | ENST00000472290.1 | n.31C>T | non_coding_transcript_exon_variant | 1/11 | 1 | |||||
GCKR | ENST00000417872.5 | n.66C>T | non_coding_transcript_exon_variant | 1/7 | 4 |
Frequencies
GnomAD3 genomes AF: 0.000171 AC: 26AN: 152188Hom.: 0 Cov.: 32
GnomAD3 genomes
AF:
AC:
26
AN:
152188
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.000199 AC: 50AN: 251438Hom.: 0 AF XY: 0.000243 AC XY: 33AN XY: 135890
GnomAD3 exomes
AF:
AC:
50
AN:
251438
Hom.:
AF XY:
AC XY:
33
AN XY:
135890
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.000198 AC: 290AN: 1461306Hom.: 0 Cov.: 30 AF XY: 0.000208 AC XY: 151AN XY: 727038
GnomAD4 exome
AF:
AC:
290
AN:
1461306
Hom.:
Cov.:
30
AF XY:
AC XY:
151
AN XY:
727038
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.000171 AC: 26AN: 152306Hom.: 0 Cov.: 32 AF XY: 0.000188 AC XY: 14AN XY: 74466
GnomAD4 genome
AF:
AC:
26
AN:
152306
Hom.:
Cov.:
32
AF XY:
AC XY:
14
AN XY:
74466
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
1
AN:
3478
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not provided Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Sep 14, 2023 | This variant has not been reported in the literature in individuals affected with GCKR-related conditions. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may create or strengthen a splice site. This variant is present in population databases (rs147430554, gnomAD 0.04%). This sequence change affects codon 3 of the GCKR mRNA. It is a 'silent' change, meaning that it does not change the encoded amino acid sequence of the GCKR protein. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
DS_DG_spliceai
Position offset: -2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at